Article Versions Notes

Martínez-Alonso E, Escobar-Peso A, Aliena-Valero A, Torregrosa G, Chioua M, Fernández-Serra R, González-Nieto D, Ouahid Y, Salom JB, Masjuan J, et al. Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke. Antioxidants. 2022; 11(6):1186. https://doi.org/10.3390/antiox11061186

Martínez-Alonso, Emma, Alejandro Escobar-Peso, Alicia Aliena-Valero, Germán Torregrosa, Mourad Chioua, Rocío Fernández-Serra, Daniel González-Nieto, Youness Ouahid, Juan B. Salom, Jaime Masjuan, and et al. 2022. "Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke" Antioxidants 11, no. 6: 1186. https://doi.org/10.3390/antiox11061186

Martínez-Alonso, E., Escobar-Peso, A., Aliena-Valero, A., Torregrosa, G., Chioua, M., Fernández-Serra, R., González-Nieto, D., Ouahid, Y., Salom, J. B., Masjuan, J., Marco-Contelles, J., & Alcázar, A. (2022). Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke. Antioxidants, 11(6), 1186. https://doi.org/10.3390/antiox11061186